Abstract
Summary
In this meta-analysis, we analyzed 9 cross-sectional studies for an association between type 1 diabetes mellitus (T1DM) and bone mineral density (BMD) in children. We found that BMD Z-scores were significantly reduced in children with T1DM.
Introduction
Recent cross-sectional studies have examined how T1DM influences bone health in children and adolescents, but the relationship between T1DM and BMD remains unclear due to conflicting reports.
Methods
In this meta-analysis, we systematically searched PubMed, Cochrane library, and Web of Science databases (for publications through March 12, 2020), and calculated weight mean difference (WMD) along with 95% confidence intervals (CI) using a random-effects model. Heterogeneity was evaluated using the I2 method. The Newcastle-Ottawa Scale was used to assess the quality of the included studies.
Results
Data were analyzed from 9 eligible studies, including a total of 1522 children and adolescents. These data were tested for an association between T1DM and BMD. This analysis found a significant decrease in BMD Z-score in the whole body (pooled WMD, − 0.47, 95% CI, − 0.92 to − 0.02, I2 = 80.2%) and lumbar spine (pooled WMD, − 0.41, 95% CI, − 0.69 to − 0.12, I2 = 80.3%) in children and adolescents with T1DM, which was consistent in published studies from Asia and South America, but inconsistent in the North America and Europe. Importantly, the differences in BMD Z-scores were independent of age, level of glucose control (HbA1c), and prepubertal stage. Sensitivity analyses did not modify these findings. Funnel plot and the Egger test did not reveal significant publication bias.
Conclusion
This meta-analysis suggests that T1DM may play a role in decreasing BMD Z-scores in the whole body and lumbar spine in children.
Similar content being viewed by others
References
Patterson C, Guariguata L, Dahlquist G, Soltész G, Ogle G, Silink M (2014) Diabetes in the young a global view and worldwide estimates of numbers of children with type 1 diabetes. Diabetes Res Clin Pract 103(2):161–175. https://doi.org/10.1016/j.diabres.2013.11.005
Craig ME, Jefferies C, Dabelea D, Balde N, Donaghue KC (2014) Definition, epidemiology, and classification of diabetes in children and adolescents (ISPAD Clinical Practice Consensus Guidelines 2014 Compendium). Pediatr Diabetes 15(Suppl 20):4–17. https://doi.org/10.1111/pedi.12186
Wołoszyn-Durkiewicz A, Myśliwiec M (2019) The prognostic value of inflammatory and vascular endothelial dysfunction biomarkers in microvascular and macrovascular complications in type 1 diabetes. Pediatr Endocrinol Diabetes Metab 25(1):28–35. https://doi.org/10.5114/pedm.2019.84710
Saki F, Sheikhi A, Omrani GHR, Karimi H, Dabbaghmanesh MH, Mousavinasab SN (2017) Evaluation of bone mineral density in children with type I diabetes mellitus and relationship to serum levels of osteopontin. Drug Res (Stuttg) 67(9):527–533. https://doi.org/10.1055/s-0043-109001
Léger J, Marinovic D, Alberti C, Dorgeret S, Chevenne D, Marchal CL, Tubiana RN, Sebag G, Czernichow P (2006) Lower bone mineral content in children with type 1 diabetes mellitus is linked to female sex, low insulin-like growth factor type I levels, and high insulin requirement. J Clin Endocrinol Metab 91(10):3947–3953. https://doi.org/10.1210/jc.2006-0711
Karagüzel G, Akçurin S, Ozdem S, Boz A, Bircan I (2006) Bone mineral density and alterations of bone metabolism in children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 19(6):805–814. https://doi.org/10.1515/jpem.2006.19.6.805
Raisingani M, Preneet B, Kohn B, Yakar S (2017) Skeletal growth and bone mineral acquisition in type 1 diabetic children; abnormalities of the GH/IGF-1 axis. Growth Horm IGF Res 34:13–21. https://doi.org/10.1016/j.ghir.2017.04.003
Cotts KG, Cifu AS (2018) Treatment of osteoporosis. JAMA 319:1040–1041. https://doi.org/10.1001/jama.2017.21995
Black DM, Rosen CJ (2016) Postmenopausal osteoporosis. N Engl J Med 374:2096–2097. https://doi.org/10.1056/NEJMc1602599
Braithwaite RS, Col NF, Wong JB (2003) Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc 51(3):364–370. https://doi.org/10.1046/j.1532-5415.2003.51110.x
Panagiotis A, Stavroula AP, Nifon NG, Aikaterini MA, Konstantinos C, Dimitrios S, Andromachi V, Michael P, Dimitrios GG (2018) Efficacy of anti-osteoporotic medications in patients with type 1 and 2 diabetes mellitus: a systematic review. Endocrine 60(3):373–383. https://doi.org/10.1007/s12020-018-1548-x
Shah VN, Harrall KK, Shah CS, Gallo TL, Joshee P, Snell-Bergeon JK, Kohrt WM (2017) Bone mineral density at femoral neck and lumbar spine in adults with type 1 diabetes: a meta-analysis and review of the literature. Osteoporos Int 28(9):2601–2610. https://doi.org/10.1007/s00198-017-4097-x
Brandao FR, Vicente EJ, Daltro CH, Sacramento M, Moreira A, Adan L (2007) Bone metabolism is linked to disease duration and metabolic control in type 1 diabetes mellitus. Diabetes Res Clin Pract 78(3):334–339. https://doi.org/10.1016/j.diabres.2007.04.009
de Souza KS, Ururahy MA, da Costa Oliveira YM, Loureiro MB, da Silva HP, Bortolin RH, Melo Dos Santos F, Luchessi AD, Neto JJ, Arrais RF, Hirata RD, das Graças Almeida M, Hirata MH, de Rezende AA (2016) Low bone mineral density in patients with type 1 diabetes: association with reduced expression of IGF1, IGF1R and TGFB1 in peripheral blood mononuclear cells. Diabetes Metab Res Rev 32(6):589–595. https://doi.org/10.1002/dmrr.2772
Dongare BS, Lohiya N, Maheshwari A, Ekbote V, Chiplonkar S, Padidela R, Mughal Z, Khadilkar V, Khadilkar A (2020) Muscle and bone parameters in underprivileged Indian children and adolescents with T1DM. Bone 130:115074. https://doi.org/10.1016/j.bone.2019.115074
Gunczler P, Lanes R, Paoli M, Martinis R, Villaroel O, Weisinger JR (2001) Decreased bone mineral density and bone formation markers - shortly after diagnosis of clinical type 1 diabetes mellitus. J Pediatr Endocrinol Metab 14(5):525–528. https://doi.org/10.1515/jpem.2001.14.5.525
Loureiro MB, Ururahy Marcela AG, Souza Karla SC, Oliveira Yonara MC, Silva Heglayne PV, Bortolin RH, Bezerra JF, Hirata Rosario DC, Maciel-Neto JJ, Arrais RF, Almeida Maria dG, Hirata MH, Rezende Adriana A (2018) Relationship between glycemic control and OPG gene polymorphisms with lower bone mineral density in patients with type 1 Diabetes mellitus. Braz J Pharm Sci 53(4):e00060. https://doi.org/10.1590/s2175-97902017000400060
Maggio AB, Ferrari S, Kraenzlin M, Marchand LM, Schwitzgebel V, Beghetti M, Rizzoli R, Farpour-Lambert NJ (2010) Decreased bone turnover in children and adolescents with well controlled type 1 diabetes. J Pediatr Endocrinol Metab 23(7):697–707. https://doi.org/10.1515/jpem.2010.23.7.697
Roh JG, Yoon JS, Park KJ, Lim JS, Lee HS, Hwang JS (2018) Evaluation of bone mineral status in prepuberal children with newly diagnosed type 1 diabetes. Ann Pediatr Endocrinol Metab 23(3):136–140. https://doi.org/10.6065/apem.2018.23.3.136
Simmons KM, McFann K, Taki I, Liu E, Klingensmith GJ, Rewers MJ, Frohnert BI (2016) Reduced bone mineral density is associated with celiac disease autoimmunity in children with type 1 diabetes. J Pediatr 169:44–48.e1. https://doi.org/10.1016/j.jpeds.2015.10.024
Tsentidis C, Gourgiotis D, Kossiva L, Doulgeraki A, Marmarinos A, Galli-Tsinopoulou A, Karavanaki K (2016) Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis. Osteoporos Int 27(4):1631–1643. https://doi.org/10.1007/s00198-015-3422-5
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535. https://doi.org/10.1136/bmj.b2535
Bashashati M, Rezaei N, Shafieyoun A, McKernan DP, Chang L, Öhman L, Quigley EM, Schmulson M, Sharkey KA, Simrén M (2014) Cytokine imbalance in irritable bowel syndrome: a systematic review and meta-analysis. Neurogastroenterol Motil 26(7):1036–1048. https://doi.org/10.1111/nmo.12358
Islam MA, Alam F, Wong KK (2017) Comorbid association of antiphospholipid antibodies and migraine: a systematic review and meta-analysis. Autoimmun Rev 16(5):512–522. https://doi.org/10.1016/j.autrev.2017.03.005
Islam MA, Alam F, Cavestro C, Calcii C, Sasongko TH, Levy RA, Gan SH (2018) Antiphospholipid antibodies in epilepsy: a systematic review and meta-analysis. Autoimmun Rev 17(8):755–767. https://doi.org/10.1016/j.autrev.2018.01.025
Higgins Julian PT, Green S (2011) Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0. [updated March 2011]. The Cochrane Collaboration. www.cochrane-handbook.org. Accessed 30 Sept 2018
Higgins Julian PT, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558. https://doi.org/10.1002/sim.1186
Pan H, Wu N, Yang T, Wei H (2014) Association between bone mineral density and type 1 diabetes mellitus: a meta-analysis of cross-sectional studies. Diabetes/Metab Res Rev 30(7):531–542. https://doi.org/10.1002/dmrr.2508
McKay HA, Petit MA, Khan KM, Schutz RW (2000) Lifestyle determinants of bone mineral: a comparison between prepubertal Asian- and Caucasian-Canadian boys and girls. Calcif Tissue Int 66(5):320–324. https://doi.org/10.1007/s002230010067
Boot AM, de Ridder MA, Pols HA, Krenning EP, de Muinck Keizer-Schrama SM (1997) Bone mineral density in children and adolescents: relation to puberty, calcium intake, and physical activity. J Clin Endocrinol Metab 82(1):57–62. https://doi.org/10.1210/jcem.82.1.3665
Napoli N, Chandran M, Pierroz DD, Abrahamsen B, Schwartz AV, Ferrari SL (2017) IOF Bone and Diabetes Working Group. Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol 13(4):208–219. https://doi.org/10.1038/nrendo.2016.153
Hough FS, Pierroz DD, Cooper C, Ferrari SL (2016) MECHANISMS IN ENDOCRINOLOGY: Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus. Eur J Endocrinol 174(4):R127–R138. https://doi.org/10.1530/EJE-15-0820
Linda G, Xiaofei H, Paul F, Scott B, Mirek K, Janet R, Mark SN (2000) Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology 141(11):3956–3964. https://doi.org/10.1210/endo.141.11.7739
Glantschnig H, Fisher JE, Wesolowski G, Rodan GA, Reszka AA (2003) M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase. Cell Death Differ 10(10):1165–1177. https://doi.org/10.1038/sj.cdd.4401285
Manolagas SC (2010) From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev 31(3):266–300. https://doi.org/10.1210/er.2009-0024
McCabe LR (2007) Understanding the pathology and mechanisms of type I diabetic bone loss. J Cell Biochem 102(6):1343–1357. https://doi.org/10.1002/jcb.21573
Botolin S, McCabe LR (2006) Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways. J Cell Biochem 99(2):411–424. https://doi.org/10.1002/jcb.20842
Sanguineti R, Puddu A, Mach F, Montecucco F, Viviani GL (2014) Advanced glycation end products play adverse proinflammatory activities in osteoporosis. Mediators Inflamm 2014(9):975872–975879. https://doi.org/10.1155/2014/975872
Neumann T, Lodes S, Kästner B, Franke S, Kiehntopf M, Lehmann T, Müller UA, Wolf G, Sämann A (2014) High serum pentosidine but not esRAGE is associated with prevalent fractures in type 1 diabetes independent of bone mineral density and glycaemic control. Osteoporos Int 25(5):1527–1533. https://doi.org/10.1007/s00198-014-2631-7
Hofbauer LC, Brueck CC, Singh SK, Dobnig H (2007) Osteoporosis in patients with diabetes mellitus. J Bone Mineral Res 22(9):1317–1328. https://doi.org/10.1359/jbmr.070510
Maggio AB, Rizzoli RR, Marchand LM, Ferrari S, Beghetti M, Farpour-Lambert NJ (2012) Physical activity increases bone mineral density in children with type 1 diabetes. Med Sci Sports Exerc 44(7):1206–1211. https://doi.org/10.1249/MSS.0b013e3182496a25
Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Kanis JA (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8:136. https://doi.org/10.1007/s11657-013-0136-1
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflicts of interest
None.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
ESM 1
(DOCX 161 kb)
Rights and permissions
About this article
Cite this article
Zhu, Q., Xu, J., Zhou, M. et al. Association between type 1 diabetes mellitus and reduced bone mineral density in children: a meta-analysis. Osteoporos Int 32, 1143–1152 (2021). https://doi.org/10.1007/s00198-020-05715-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-020-05715-3